-
Genesis MedTech Group Raises Significant Growth Investment in Latest Round of Series B Financing
prnasia
May 24, 2021
Genesis MedTech Group, a leading medical device company, announced it has completed its Series B round, raising significant growth financing. General Atlantic, a leading global growth equity firm, led the funding with participation from CITIC Capital ...
-
Shockwave Announces Joint Venture In China with Genesis MedTech Group
prnasia
March 23, 2021
Shockwave Medical, Inc., a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today that the company has signed an agreement to form a joint venture with Genesis MedTech Group to ...
-
Genesis Drug Discovery & Development Acquires Integrated Analytical Solutions
contractpharma
March 05, 2021
Genesis Biotechnology Group (GBG) and its Contract Research Organization (CRO) arm Genesis Drug Discovery & Development (GD3) have acquired the Berkeley-based CRO Integrated Analytical Solutions (IAS).
-
Genesis Medtech Collaborates with Penumbra to Expand Neurovascular Market in China
prnasia
January 20, 2021
Genesis MedTech Group has reached a consensus to fully acquire Hua Medtech as part of its plans to set up a specialised neurovascular franchise, which has entered into a strategic cooperation with Penumbra, Inc., an NYSE listed, global healthcare ...
-
Genesis Aquires NexusPharma
contractpharma
June 19, 2019
Expands preclinical contract research portfolio and integrates unique xenograft models.
-
Genesis Healthcare raises 1.65 B Yen
biospectrumasia
February 27, 2018
The new capital will further strengthen the partnership as the addition of biometric information such as blood pressure from Omron's precision wearable devices will maximize the utility of Genesis' genetic data-sharing platform.